Any thoughts to our Phase 2 success rate?
https://en.wikipedia.org/wiki/Phases_of_clinical_research
Success rate
Phase II clinical programs historically have experienced the lowest success rate of the four development phases. In 2010, the percentage of phase II trials that proceeded to phase III was 18%,[10] and only 30.7% of developmental candidates advanced from Phase II to Phase III in a large study of trials from 2006-2015.[
Churn churn churn, page-16
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.010(2.78%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 33.5¢ | $2.103M | 6.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 32406 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 234417 | 5 |
View Market Depth
| Last trade - 16.10pm 02/12/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
